Circle Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Circle Pharma Inc (Circle Pharma) is a developer of cell permeable macrocyclic peptide therapies by combining structure-based computational design and synthetic chemistry. The companys automated chemistry synthesis enable to assess, in parallel, multiple design hypotheses for given target, and rapidly explore structure activity relationships. Its technology platform finds applications in a range of disease conditions including fibrosis; infection; inflammation; and indications such as cardiovascular, metabolism, neurology and pain. The companys pipeline targets include beta-catenin, MCL1, cyclinA, cdk2 and p53. Circle Pharma is headquartered in South San Francisco, California, the US.

Circle Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Circle Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Circle Pharma Raises Additional USD2 million in Series A Financing 10
Circle Pharma Raises Funds through Series A Preferred Stock Financing 11
Circle Pharma Raises USD3.8 Million in Venture Financing 12
Circle Pharma Raises Additional Funds through Seed Financing 13
Circle Pharma Raises Funds through Seed Financing 14
Partnerships 15
Circle Pharma Partners with Pfizer 15
Circle Pharma Inc - Key Competitors 16
Circle Pharma Inc - Key Employees 17
Circle Pharma Inc - Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Product News 19
11/20/2017: Circle Pharma Announces Appointment of David Spellmeyer, PhD, as Chief Scientific Officer 19
01/17/2018: Circle Pharma Announces Publication in Journal of Medicinal Chemistry of Results from Collaboration with Pfizer Inc. 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List Of Tables


Circle Pharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Circle Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Circle Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Circle Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Circle Pharma Raises Additional USD2 million in Series A Financing 10
Circle Pharma Raises Funds through Series A Preferred Stock Financing 11
Circle Pharma Raises USD3.8 Million in Venture Financing 12
Circle Pharma Raises Additional Funds through Seed Financing 13
Circle Pharma Raises Funds through Seed Financing 14
Circle Pharma Partners with Pfizer 15
Circle Pharma Inc, Key Competitors 16
Circle Pharma Inc, Key Employees 17

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Circle Pharma Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Circle Pharma Inc (Circle Pharma) is a developer of cell permeable macrocyclic peptide therapies by combining structure-based computational design and synthetic chemistry. The companys automated chemistry synthesis capability enables us

USD 250 View Report

Circle Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Circle Pharma Inc (Circle Pharma) is a developer of cell permeable macrocyclic peptide therapies by combining structure-based computational design and synthetic chemistry. The companys automated chemistry synthesis enable to assess,

USD 250 View Report

Avisa Pharma Inc - Product Pipeline Analysis, 2019 Update

Avisa Pharma Inc (Avisa Pharma) is a medical device company that develops breath tests system for the diagnosis of pulmonary infections. The company provides product such as avisa breath test

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available